Emdeon Selects IBM in Master Patient Index Software Licensing Deal

IBM Technology Will Enable Emdeon to Deliver Real-Time Patient Information at the Point of Care

NASHVILLE, Tenn. and ORLANDO, Fla., Feb. 21, 2011 /PRNewswire-FirstCall/ -- HIMSS -- Emdeon Inc. (NYSE: EM), one of the largest health information networks in the nation focusing on clinical exchange and a leading provider of healthcare revenue and payment cycle management solutions, today announced the selection of IBM (NYSE: IBM) as its technology provider for patient-centric clinical information exchange.

The five-year, multi-phased software licensing deal for IBM Initiate Patient will allow Emdeon the ability to assemble a virtual view of patient data for use by healthcare providers. This virtual patient view will be populated with data from Emdeon's clinical information network that today processes over 150 million clinical and ePrescribing information exchanges per year. IBM Initiate Patient accurately identifies patients to enable targeted delivery of clinical information to healthcare providers at the point of care and within their routine software workflow. Through Emdeon's health information network, authorized healthcare providers will be able to retrieve a patient's medication history or other clinical information through a single query of Emdeon's vast data resources and receive results within seconds of the request. The first phase of the multi-phase project between Emdeon and IBM will focus on medication reconciliation, electronic prescribing data and the patient's medical history; all delivered to authorized healthcare providers to help improve patient outcomes.

"Emdeon's leading health information network sustains a tremendous amount of data from the majority of patients, providers, pharmacies and payers in the U.S.," said George Lazenby, chief executive officer for Emdeon. "This data can give healthcare providers important information about their patients at the point of care. IBM Initiate Patient gives us the ability to produce a portable, powerful and accurate healthcare record within our existing nationwide network to enable the healthcare industry to leap forward in its pursuit of patient-centric healthcare."

IBM Initiate Patient touches 80 percent of the population of North America. Relied upon by more than 100 healthcare systems, more than 40 health information exchanges and many of the nation's largest retail pharmacies, IBM is the trusted foundation of health information exchange initiatives around the globe. IBM's deep expertise in this area is based on nearly 20 years of work creating interoperable health information projects, including work with the IBM Healthcare Collaborative Network and the prototype of the Nationwide Health Information Network (NHIN).

"The accurate patient identification provided by IBM Initiate Patient is a pre-requisite to exchanging clinical information among the distinctly different stakeholders participating in a health information network like Emdeon's," said Sean Cassidy, director, healthcare products, information management, IBM Software Group. "We are excited to be part of Emdeon's efforts to transform how healthcare is delivered by providing better access to information."

Emdeon will host an educational presentation with IBM at booth number 2201 at the Healthcare Information and Management Systems Society (HIMSS) national conference in Orlando, February 21-23, 2011. More information, as well as the HIMSS schedule for all of the Emdeon in-booth speaking events, can be found online at http://www.emdeon.com/HIMSS11.

About Emdeon

Emdeon is a leading provider of revenue and payment cycle management solutions, connecting payers, providers and patients in the U.S. healthcare system. Emdeon's product and service offerings integrate and automate key business and administrative functions of its payer and provider customers throughout the patient encounter. Through the use of Emdeon's comprehensive suite of products and services, which are designed to easily integrate with existing technology infrastructures, customers are able to improve efficiency, reduce costs, increase cash flow and more efficiently manage the complex revenue and payment cycle process. For more information, visit www.emdeon.com.

About IBM

For more information about IBM, visit: http://www.ibm.com/smarterhealthcare.

Follow us on Twitter @IBMHealthcare or http://twitter.com/ibmhealthcare

Join in the discussion on the Smarter Healthcare LinkedIn Group

Watch our videos at www.youtube.com/ibmhealthcare

Statements made in this press release that express Emdeon's or management's intentions, plans, beliefs, expectations or predictions of future events are forward-looking statements, which Emdeon intends to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. These statements often include words such as "may," "will," "should," "believe," "expect," "anticipate," "intend," "plan," "estimate" or similar expressions. Forward-looking statements also may include information concerning Emdeon's possible or assumed future results of operations, including descriptions of Emdeon's revenues, profitability and outlook and its overall business strategy. You should not place undue reliance on these statements because they are subject to numerous uncertainties and factors relating to Emdeon's operations and business environment, all of which are difficult to predict and many of which are beyond Emdeon's control. Although Emdeon believes that these forward-looking statements are based on reasonable assumptions, you should be aware that many factors could affect Emdeon's actual financial results or results of operations and could cause actual results to differ materially from those in the forward-looking statements, including the risks discussed in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections and elsewhere in Emdeon's Annual Report on Form 10-K for the year ended December 31, 2009, as well as Emdeon's periodic and other reports, filed with the Securities and Exchange Commission.

You should keep in mind that any forward-looking statement made by Emdeon herein, or elsewhere, speaks only as of the date on which made. Emdeon expressly disclaims any intent, obligation or undertaking to update or revise any forward-looking statements made herein to reflect any change in Emdeon's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based.

SOURCE Emdeon Inc.